Brief: NantHealth enters into reseller agreement with Lunatus
05/12/2016 15:05
Dec 5 (Reuters) - NantHealth Inc NH.O :
* Entered into an exclusive reseller agreement for GPS
cancer advanced molecular analysis with Lunatus
* Under terms of agreement, Lunatus will have exclusive
rights to distribute GPS cancer to physicians in Middle East
Source text for Eikon: ID:nBw9qtLW5a
Further company coverage: NH.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Nanthealth
See all newsNantHealth plunges on Nasdaq share suspension notice
Brief: Nanthealth Inc On May 22 Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On May 24
Brief: NantHealth Announces 1-For-15 Reverse Stock Split
NantHealth Inc reports results for the quarter ended in March - Earnings Summary
Brief: NantHealth Reports 2022 First Quarter Financial Results